News

Published on 6 Apr 2024 on Simply Wall St. via Yahoo Finance

Evolus, Inc. (NASDAQ:EOLS) is favoured by institutional owners who hold 57% of the company


Article preview image

Key Insights

Given the large stake in the stock by institutions, Evolus' stock price might be vulnerable to their trading decisions53% of the business is held by the top 10 shareholders Insiders have been selling lately

Every investor in Evolus, Inc. (NASDAQ:EOLS) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 57% to be precise, is institutions. Put another way, the group faces the maximum upside potential (or downside risk).

NASDAQ.EOLS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Evolus, Inc.'s (NASDAQ:EOLS) Path To Profitability

Evolus, Inc. (NASDAQ:EOLS) is possibly approaching a major achievement in its business, so we wou...

Simply Wall St. · via Yahoo Finance 20 Dec 2024

Evolus Inc (EOLS) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Market...

Net Revenue: $61.1 million for Q3 2024, a 22% increase compared to Q3 2023. Gross Margin: Reporte...

GuruFocus.com · via Yahoo Finance 7 Nov 2024

Evolus Inc (EOLS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and...

Revenue: $66.9 million in Q2 2024, representing 36% growth over the prior year. Gross Margin:...

GuruFocus.com · via Yahoo Finance 11 Oct 2024

Evolus, Inc. (EOLS): Is It One of Caligan Partners’ Top Holdings Now?

We recently compiled a list of the Top 10 Holdings of Caligan Partners. In this article, we are...

Insider Monkey · via Yahoo Finance 13 Aug 2024

Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript

Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript May 7, 2024 Evolus, Inc. misses on ea...

Insider Monkey via Yahoo Finance 8 May 2024

Evolus Inc (EOLS) Q1 2024 Earnings: Surpasses Revenue Estimates with Significant Growth

Q1 2024 Revenue: $59.3 million, a 42% increase from Q1 2023, surpassing the estimated $57.32 mill...

GuruFocus.com via Yahoo Finance 7 May 2024

3 Top Stocks to Invest in for Amazing Earnings Acceleration

Companies’ earnings growth captivates almost everyone, from the top brass to research analysts. S...

Zacks via Yahoo Finance 25 Apr 2024

Evolus, Inc. (NASDAQ:EOLS) is favoured by institutional owners who hold 57% of the company

Key Insights Given the large stake in the stock by institutions, Evolus' stock price might be vul...

Simply Wall St. via Yahoo Finance 6 Apr 2024

Evolus, Inc. (NASDAQ:EOLS) Q4 2023 Earnings Call Transcript

Evolus, Inc. (NASDAQ:EOLS) Q4 2023 Earnings Call Transcript March 7, 2024 Evolus, Inc. isn't one ...

Insider Monkey via Yahoo Finance 8 Mar 2024

11 Best Small Cap Pharma Stocks to Invest In

In this piece, we will take a look at the 11 best small cap pharma stocks to invest in. If you wa...

Insider Monkey via Yahoo Finance 5 Mar 2024